SCHEMBL9989282

SCHEMBL9989282

Cc1ccc(C(=O)N[C@H](C)C2CCCCC2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
CNR2 P34972 2/20 0.51
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ACKR3 P25106 1/20 0.48
IDO1 P14902 3/20 0.48
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
JAK2 O60674 1/20 0.46
JAK1 P23458 1/20 0.46
JAK3 P52333 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7453238 1.00 HDAC1 (0.51) HDAC1HDAC6CNR2KDM4EALDH1A1
SCHEMBL17865784 0.84 CNR2 (0.57) CNR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL7452804 0.83 KDM4E (0.49) CNR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL9988723 0.83 KDM4E (0.49) CNR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL7458204 0.82 KDM4E (0.48) CNR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL9990244 0.82 KDM4E (0.48) CNR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL21489815 0.81 SMYD3 (0.67)
SCHEMBL19710485 0.81 SMYD3 (0.67)
SCHEMBL5429490 0.81 HDAC1 (0.66) HDAC1HDAC6KDM4EALDH1A1HPGD
SCHEMBL5429612 0.80 NPC1 (0.65) HDAC1HDAC6ALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969389-B2 Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators VANDERBILT UNIVERSITY (US) 2015-03-03 US disclosed
CN-103037693-A Substituted-6-methylnicotinamides as MGLUR5 positive allosteric modulators UNIV VANDERBILT 2013-04-10 CN disclosed
US-20110294858-A1 SUBSTITUTED 6-METHYLNICOTINAMIDES AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294858-A1 SUBSTITUTED 6-METHYLNICOTINAMIDES AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS GRM5, GRIK5, GRM6 HDAC1 1037/4885HDAC6 787/4885CNR2 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.